Respiro Diagnostics has secured £1M in pre-seed funding led by Zinc Venture Capital to advance its breath-based diagnostics for lung diseases.
Amount Raised
£1 Million
Round Type
Pre-Seed
United KingdomBiotechnologyHealth CareMedical DeviceTherapeuticsHealth DiagnosticsInvestors
Description
Respiro Diagnostics, a UK-based startup, has raised £1 million in a pre-seed funding round. The funding will support clinical research and development of a non-invasive device for lung diagnostics. Led by Zinc Venture Capital, this round includes several notable investors. The company aims to provide early diagnosis through breath samples, potentially transforming lung disease diagnostics.
Quick answer
Respiro Diagnostics raised £1 Million in a Pre-Seed round, dated July 8, 2026. Investors: SFC Capital, Amadeus Capital Partners, Conception X Angel Syndicate, Kq Labs, Innovate UK and Zinc Venture Capital. Respiro Diagnostics is based in United Kingdom.
- How much did Respiro Diagnostics raise?
- Respiro Diagnostics raised £1 Million in a Pre-Seed round on July 8, 2026.
- Who invested in Respiro Diagnostics?
- SFC Capital, Amadeus Capital Partners, Conception X Angel Syndicate, Kq Labs, Innovate UK and Zinc Venture Capital are named as investors in this round.
- What does Respiro Diagnostics do?
- Respiro Diagnostics is a UK-based startup focused on developing breath-based diagnostics for lung diseases.
- Where is Respiro Diagnostics based and how big is it?
- Respiro Diagnostics is based in United Kingdom. Fundz records about 3 employees.
- Who are the decision-makers at Respiro Diagnostics?
- Fundz holds 1 contact at Respiro Diagnostics, including the Co-Founder and CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical Device and Therapeutics around the same time
Companies in the same sectors as Respiro Diagnostics that raised within 45 days of this round, from Fundz verified event records.
- Imagion Biosystems raised $2.8M (Post-IPO Equity) on June 25, 2026.
- bioAffinity Technologies raised $4M (Post-IPO Equity) on August 14, 2026.
- Ayati Devices raised $1.6M (Pre-Series A) on August 11, 2026.
- Vexev raised $6M on August 6, 2026.
- Mediqstar raised an undisclosed amount (Series B) on August 3, 2026.
- TidalSense raised $19M on July 24, 2026.
Who to call at Respiro Diagnostics, and when
A new round usually means Respiro Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Respiro Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Respiro Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Respiro Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Respiro Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Respiro Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.